Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;42(3):295-306.
doi: 10.1007/s00059-016-4470-0. Epub 2016 Oct 26.

Efficacy and safety of aspirin combined with warfarin after acute coronary syndrome : A meta-analysis

Affiliations
Review

Efficacy and safety of aspirin combined with warfarin after acute coronary syndrome : A meta-analysis

P Zhang et al. Herz. 2017 May.

Abstract

A comprehensive meta-analysis was performed to investigate whether the combination of high-/low-dose of aspirin and various intensities of warfarin (W) offer greater benefit than aspirin (ASA) alone. A total of 14 randomized clinical trials (RCTs) having 26,916 patients with acute coronary syndrome (ACS) met inclusion criteria. The efficacy and safety of all outcomes which included myocardial infarction (MI), all-cause death, stroke, and bleeding were calculated. The overall outcomes analysis showed there was no significant difference in the risk of MI (relative ratio [RR] 0.959, 95 % confidence interval [CI] 0.78-1.04, P = 0.308), stroke (RR 0.789, 95 % CI 0.57-1.09, P = 0.145), and all-cause death (RR 1.007, 95 % CI 0.93-1.09, P = 0.87) between the combination group and ASA group. The subgroup analysis suggested that ASA (≤100 mg/day) plus W (mean international normalized ratio [INR] 2.0-3.0) decreased the risk rate of stroke (RR 0.660, 95 % CI 0.50-0.87, P = 0.003). There was a lower risk of MI (RR 0.605, 95 % CI 0.47-0.77, P < 0.0001) as well as stroke (RR 0.594, 95 % CI 0.45-0.79, P < 0.0001) between W (INR 2.0-3.0) combined with ASA (mean dose ≥100 mg/day) and ASA. However, the risk of major bleeding (RR 1.738, 95 % CI 1.45-2.08, P < 0.0001) and minor bleeding (RR 2.767, 95 % CI 2.12-3.61, P < 0.0001) was almost doubled in the combined groups. Compared with ASA, high-dose aspirin with moderate-intensity warfarin (INR 2.0-3.0) may better reduce the risk of MI and stroke but confer an increased risk of bleeding.

Keywords: All-cause death; Anticoagulants; Bleeding; Myocardial infarction; Stroke.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Angiology. 2004 Jan-Feb;55(1):17-20 - PubMed
    1. Stat Med. 2002 Jun 15;21(11):1539-58 - PubMed
    1. Am J Med. 2010 Mar;123(3):250-8 - PubMed
    1. Control Clin Trials. 1986 Sep;7(3):177-88 - PubMed
    1. Circulation. 2002 Aug 6;106(6):659-65 - PubMed

MeSH terms

LinkOut - more resources